Clinical Trial Update: Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the termination of a Phase 1/2 study of chemotherapy followed by infusion of DMF5 cells for metastatic melanoma, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• DMF5 cell therapy (DMF5 TCR-engineered T cells)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Melanoma, Malignant Melanoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2012-06-07